Exact Mass: 466.0866334000001
Exact Mass Matches: 466.0866334000001
Found 309 metabolites which its exact mass value is equals to given mass value 466.0866334000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Plantagoside
Plantagoside is a flavanone glycoside that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7, 4 and 5 and a beta-D-glucopyranosyloxy group at position 3 respectively. It has a role as a plant metabolite. It is a flavanone glycoside, a tetrahydroxyflavanone, a monosaccharide derivative, a beta-D-glucoside and a member of 4-hydroxyflavanones. It is functionally related to a (2S)-flavanone. Plantagoside is a natural product found in Plantago asiatica, Plantago major, and other organisms with data available. A flavanone glycoside that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7, 4 and 5 and a beta-D-glucopyranosyloxy group at position 3 respectively. Plantagoside, isolated from the seeds of Plantago asiatica, is a specific and non-competitive inhibitor for jack bean α-mannosidase, with an IC50 of 5 μM[1]. Plantagoside, isolated from the seeds of Plantago asiatica, is a specific and non-competitive inhibitor for jack bean α-mannosidase, with an IC50 of 5 μM[1].
Silandrin
Constituent of Silybum marianum (milk thistle). Silandrin is found in coffee and coffee products and green vegetables. Silandrin is found in coffee and coffee products. Silandrin is a constituent of Silybum marianum (milk thistle).
6-Chloro-5-methyl-N-(6-((2-methylpyridin-3-yl)oxy)pyridin-3-yl)indoline-1-carboxamide dihydrochloride
SB 242084 dihydrochloride is a selective, competitive and high-affinity (pKi=9.0) 5-HT2C receptor antagonist (crosses the blood-brain barrier). SB 242084 dihydrochloride increases basal activity of dopaminergic neurons in the ventral tegmental area (VTA) of the midbrain and dopamine release in the vomeronasal nucleus. SB 242084 dihydrochloride also increases mitochondrial gene expression and oxidative metabolism via 5-HT2A receptor. SB 242084 dihydrochloride has good research potential in the negative symptoms of anxiety, depression and schizophrenia, as well as in acute organ damage[1][2][3].
Glucodistylin
Glucodistylin is a polyphenol compound found in foods of plant origin (PMID: 20428313). A polyphenol compound found in foods of plant origin (PhenolExplorer)
Silyhermin
Constituent of Silybum marianum (milk thistle). Silyhermin is found in coffee and coffee products and green vegetables. Silyhermin is found in coffee and coffee products. Silyhermin is a constituent of Silybum marianum (milk thistle).
Neosilyhermin A
Constituent of Silybum marianum (milk thistle). Neosilyhermin A is found in coffee and coffee products and green vegetables. Neosilyhermin B is found in coffee and coffee products. Neosilyhermin B is a constituent of Silybum marianum (milk thistle).
BL IV
BL IV is found in mushrooms. BL IV is a constituent of the kurukawa mushroom (Boletopsis leucomelas) (edibility not reported)
hesperetin-7-O-glucuronide
hesperetin-7-O-glucuronide is metabolite of the citrus fruit hesperitin.
(-)-Epicatechin 3'-O-glucuronide
(-)-Epicatechin 3-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
(-)-Epicatechin 7-O-glucuronide
(-)-Epicatechin 7-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Catechin 7-glucuronide
Catechin 7-glucuronide belongs to the class of organic compounds known as flavonoid-7-O-glucuronides. These are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to glucuronic acid at the C7-position. BioTransformer predicts that catechin 7-glucuronide is a product of catechin metabolism via an aromatic-OH-glucuronidation and catalyzed by the UDP-glucuronosyltransferase 1-1 (P22309) enzyme (PMID: 30612223).
Catechin 3'-glucuronide
Catechin 3-glucuronide belongs to the class of organic compounds known as flavonoid O-glucuronides. These are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to glucuronic acid. BioTransformer predicts that catechin 3-glucuronide is a product of catechin metabolism via an aromatic-OH-glucuronidation and catalyzed by the UDP-glucuronosyltransferase 1-1 (P22309) enzyme (PMID: 30612223).
Catechin 3-glucuronide
Epicatechin 3-glucuronide
Catechin 4'-glucuronide
Catechin 5-glucuronide
Epicatechin 4'-glucuronide
Epicatechin 5-O-glucuronide
Epicatechin 5-O-glucuronide (E5G) belongs to the class of organic compounds known as flavonoid O-glucuronides. These are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to glucuronic acid. E5G is an extremely weak basic (essentially neutral) compound (based on its pKa).
Acyclonucleoside
benfotiamine
C19H23N4O6PS (466.10758680000004)
A - Alimentary tract and metabolism > A11 - Vitamins > A11D - Vitamin b1, plain and in combination with vitamin b6 and b12 > A11DA - Vitamin b1, plain D064449 - Sequestering Agents > D002614 - Chelating Agents D007155 - Immunologic Factors
Esaxerenone
C22H21F3N2O4S (466.11740620000006)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent
(4-Chlorophenyl) (1R)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate
C25H20Cl2N2O3 (466.08509100000003)
(2S,3S,4S,5R)-3,4,5-Trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)phenoxy]oxane-2-carboxylic acid
(2S,3S,4S,5R)-6-[[2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
Atecegatran
C21H21ClF2N4O4 (466.1219320000001)
Dihydromyricetin 3-rhamnoside
Dihydromyricetin 3-rhamnoside is a member of the class of compounds known as flavonoid-3-o-glycosides. Flavonoid-3-o-glycosides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C3-position. Dihydromyricetin 3-rhamnoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Dihydromyricetin 3-rhamnoside can be found in grape wine, which makes dihydromyricetin 3-rhamnoside a potential biomarker for the consumption of this food product.
2-(alpha-hydroxyethyl)thiamine diphosphate
2-(alpha-hydroxyethyl)thiamine diphosphate, also known as 2-(α-hydroxyethyl)-tpp, is a member of the class of compounds known as thiamine phosphates. Thiamine phosphates are thiamine derivatives in which the hydroxyl group of the ethanol moiety is substituted by a phosphate group. 2-(alpha-hydroxyethyl)thiamine diphosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 2-(alpha-hydroxyethyl)thiamine diphosphate can be found in a number of food items such as amaranth, wild rice, date, and elliotts blueberry, which makes 2-(alpha-hydroxyethyl)thiamine diphosphate a potential biomarker for the consumption of these food products. 2-(α-hydroxyethyl)thiamine diphosphate, also known as 2-(α-hydroxyethyl)-tpp, is a member of the class of compounds known as thiamine phosphates. Thiamine phosphates are thiamine derivatives in which the hydroxyl group of the ethanol moiety is substituted by a phosphate group. 2-(α-hydroxyethyl)thiamine diphosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 2-(α-hydroxyethyl)thiamine diphosphate can be found in a number of food items such as amaranth, wild rice, date, and elliotts blueberry, which makes 2-(α-hydroxyethyl)thiamine diphosphate a potential biomarker for the consumption of these food products.
3,5,7,3,4-Pentahydroxyflavanone 7-alpha-D-glucopyranoside
Silymonin
Taxifolin 7-glucoside
Taxifolin 7-glucoside is a natural product found in Podocarpus nivalis, Picea abies, and other organisms with data available. Taxifolin 7-O-β-D-glucoside (Taxifolin 7-O-glucoside) is one of the main metabolites at the seed germination stage in Scutellaria baicalensis. Taxifolin 7-O-β-D-glucoside, a flavonoid, mainly exists in the episperm and participates in defending against pathogens and UV-damage[1].
Isoglucodistylin
Neosilyhermin A
Silandrin
A flavonolignan isolated from milk thistle, Silybum marianum, and has been shown to exhibit hepatoprotective activity.
CP-471358
CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4194; ORIGINAL_PRECURSOR_SCAN_NO 4193 CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4227; ORIGINAL_PRECURSOR_SCAN_NO 4226 CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4216; ORIGINAL_PRECURSOR_SCAN_NO 4215 CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4209; ORIGINAL_PRECURSOR_SCAN_NO 4208 CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4226; ORIGINAL_PRECURSOR_SCAN_NO 4225 CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4182; ORIGINAL_PRECURSOR_SCAN_NO 4177 CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8683; ORIGINAL_PRECURSOR_SCAN_NO 8681 CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8696; ORIGINAL_PRECURSOR_SCAN_NO 8693 CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8719; ORIGINAL_PRECURSOR_SCAN_NO 8714 CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8737; ORIGINAL_PRECURSOR_SCAN_NO 8734 CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8736; ORIGINAL_PRECURSOR_SCAN_NO 8733 CONFIDENCE standard compound; INTERNAL_ID 1259; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8747; ORIGINAL_PRECURSOR_SCAN_NO 8743
EP_M467
C20H20ClFN4O4S (466.08777620000006)
CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2204
5-O-beta-D-(6-O-vanilloylglucopyranosyl)gentisic acid|5-O-??-D-(6-O-Vanilloyl glucopyranosyl) gentisic acid
2-O-beta-D-Glucopyranoside-2,3,4,5,7-Pentahydroxyflavanone
3,4-Dimethoxy-5,8-dihydroxy-xanthon-1-O-beta-D-glucopyranosid|corymbiferin 1-O-glucoside|corymbiferin-1-O-glucoside
(2R)-2,4,6-trihydroxy-2-[(3,4-dihydroxyphenyl)methyl]-3(2H)-benzofuranone-4-yl-beta-D-glucopyranoside|alphitonin-4-O-beta-D-glucopyranoside
quercetin 3-(beta-D-glucopyranoside)|quercetin-3-O-glucoside
(-)(2S)-5,6,7,3,5-pentahydroxyflavanone-7-O-beta-D-glucopyranoside
9,8-[1-Hydroxy-2-(4-hydroxyphenyl)ethylene]-13-oxa-13H-indeno[1,2-l]phenanthrene-3,5,7,11-tetraol
2-(hydroxymethyl)-4-oxo-4Hpyran-3-yl 3-O-beta-D-glucopyranosyl-beta-D-glucopyranoside|petrorhagioside A
(3R,3aR,6R,7aR,8R)-(9CI)|4-[(2S)-3,4-dihydro-5,7-dihydroxy-4-oxo-2H-1-benzopyran-2-yl]-2,3,3a,7a-tetrahydro-7a-hydroxy-8-(4-hydroxy-3-methoxyphenyl)-3,6-methanobenzo-furan-7(6H)-one|silydianin|silymonin
2-(hydroxymethyl)-4-oxo-4H-pyran-3-yl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside|petrorhagioside C
epicatechin-(7,8-bc)-4alpha-(3-methoxy-4-hydroxy-phenyl)-dihydro-2(3H)-pyranone|smiglabrone B
1-glycerophophoryl-2-hydroxy-3-<5-deoxy-5-(dimethylarsinoyl)-beta-ribofuranosyloxy>propane|1-glycerophophoryl-2-hydroxy-3-[5-deoxy-5-(dimethylarsinoyl)-beta-ribofuranosyloxy]propane
C13H28AsO11P (466.0585128000001)
4-chloro-5-hydroxyl-3-methyl-phenyl O-alpha-L-rhamnopyranosyl-(1?6)-beta-D-glucopyranoside
C19H27ClO11 (466.12418219999995)
1-O-(beta-D-glucopyranosyl)-4,7-dihydroxy-3,8-dimethoxyxanthone|kouitchenside C
6-carboxy-2,6-dihydroxy-2-beta-glucopyranosyloxy-4-hydroxymethyl-benzophenone|cassiaphenone A-2-glucoside
4-O-beta-D-(6-O-gentisoylglucopyranosyl)vanillic acid
11-O-galloylbergenin|11-O-Galloylnorbergenin|6-O-galloylnorbergenin
(2S,3S)-(-)-Taxifolin 3-glucoside;(2S,3S)-Taxifolin 3-glucoside
isoquercitrin|taxifolin 3-O-beta-D-glucopyranoside
benfotiamine
C19H23N4O6PS (466.10758680000004)
A - Alimentary tract and metabolism > A11 - Vitamins > A11D - Vitamin b1, plain and in combination with vitamin b6 and b12 > A11DA - Vitamin b1, plain D064449 - Sequestering Agents > D002614 - Chelating Agents D007155 - Immunologic Factors
1-(3,4-dihydroxyphenyl)-3-(3-C-glucosyl-2,4,6-trihydroxyphenyl)propane-1,3-dione
AChE/BChE-IN-11
(2S,3S)-3,5,7-trihydroxy-2-[4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one
4-[(2S,3R,4S,5S,6R)-6-[(3,4-dihydroxybenzoyl)oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxybenzoic acid
(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-[(3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,3-dihydrochromen-4-one
(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one
(2S,3S)-3,5,7-trihydroxy-2-[4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one [IIN-based: Match]
(2S,3S)-3,5,7-trihydroxy-2-[4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one [IIN-based on: CCMSLIB00000845144]
(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-[(3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,3-dihydrochromen-4-one [IIN-based: Match]
Cys Cys Asn Gln
Cys Cys Gln Asn
Cys Asp Asp Asp
Cys Asn Cys Gln
Cys Asn Gln Cys
Cys Gln Cys Asn
Cys Gln Asn Cys
Asp Cys Asp Asp
Asp Asp Cys Asp
Asp Asp Asp Cys
Asn Cys Cys Gln
Asn Cys Gln Cys
Asn Gln Cys Cys
Gln Cys Cys Asn
Gln Cys Asn Cys
Gln Asn Cys Cys
hesperetin-7-O-glucuronide
Glucodistylin
Epicatechin 3'-O-glucuronide
Epicatechin 7-O-glucuronide
Ziprasidone Hydrochloride Monohydrate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Ziprasidone (CP-88059) hydrochloride monohydrate is an orally active combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone hydrochloride monohydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].
4-oxopent-2-en-2-olate,thulium(3+)
C15H21O6Tm (466.06803160000004)
Varlitinib
C22H19ClN6O2S (466.09786640000004)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
2-METHANESULFONYL-5-(TRIFLUOROMETHYL)-1,3,4-THIADIAZOLE
C23H22N4O5S (466.13108420000003)
(1s,4s)-(+)-2-naphthalen-2-ylmethyl-2,5-diaza-bicyclo[2.2.1]heptane 2cf3cooh
THYMIDINE 5-MONOPHOSPHATE P-NITROPHENYL ESTER SODIUM SALT
C16H18N3NaO10P (466.06274780000007)
MK-8245
MK-8245 is a potent, liver-targeted stearoyl-CoA desaturase (SCD) inhibitor, with IC50s of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with antidiabetic and antidyslipidemic efficacy[1].
N,N-bis(2-methylpropyl)carbamodithioate,nickel(2+)
C18H36N2NiS4 (466.11146859999997)
5-[(2R)-2-([(2R)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL]AMINO)PROPYL]-1,3-BENZODIOXOLE-2,2-DICARBOXYLATE DISODIUM
C20H19ClNNa2O7 (466.06453940000006)
6-bromo-2-[4-(diethylamino)phenyl]-1-ethylbenz[cd]indolium acetate
bis(2,4,6-trimethylpyridine)bromonium hexafluorophosphate
C16H22BrF6N2P (466.06080740000004)
2-Chloro-5-{[(3,4,5-triethoxybenzoyl)carbamothioyl]amino}benzoic acid
C21H23ClN2O6S (466.09652880000004)
sodium 4-chloro-3-[[4-[(4-ethoxyphenyl)azo]phenyl]azo]benzenesulphonate
C20H16ClN4NaO4S (466.0478446000001)
1(2H)-Isoquinolinone, 5,8-dichloro-2-((1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl)-3,4-dihydro-7-((R)-methoxy-3-oxetanylmethyl)-
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor
(4-Chlorophenyl) 6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate
C25H20Cl2N2O3 (466.08509100000003)
C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
4-[3-(5-bromo-2-propoxyphenyl)-5-(4-chlorophenyl)-1H-pyrrol-2-yl]pyridine
C24H20BrClN2O (466.04474400000004)
N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide
C22H18N4O2S3 (466.05918479999997)
7-Anilino-3-(4-bromophenyl)-5-morpholino-1,4-thiazepine-6-carbonitrile
C22H19BrN4OS (466.04628640000004)
3-(1,3-Benzothiazol-2-YL)-2-(1,4-dioxo-1,2,3,4-tetrahydrophthalazin-6-YL)-5-[(E)-2-phenylvinyl]-3H-tetraazol-2-ium
Esaxerenone
C22H21F3N2O4S (466.11740620000006)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent
3-[[4-(4-Fluorophenoxy)benzenesulfonyl]-(1-hydroxycarbamoylcyclopentyl)amino]propionic acid
(-)-Epicatechin 3'-O-glucuronide
(-)-Epicatechin 3-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
S-[(1R,2R)-1-(2-chlorophenyl)-2-(4-fluorophenyl)-1,3-dihydroxy-3-(1H-1,2,4-triazol-1-yl)propan-2-yl]-L-cysteine
C20H20ClFN4O4S (466.08777620000006)
1-(3,4-dihydroxyphenyl)-3-[2,4,6-trihydroxy-3-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl]propane-1,3-dione
(2S,3S,4S,5R)-6-[[2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride hydrate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
5-(2-furanyl)-N-[1-[(2-methylphenyl)methyl]-3-pyrazolyl]-7-(trifluoromethyl)-3-pyrazolo[1,5-a]pyrimidinecarboxamide
C23H17F3N6O2 (466.13650179999996)
4-(Difluoromethoxy)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
N-(4-chloro-2-methoxy-5-methylphenyl)-4-[(3,4-difluorophenyl)sulfonylamino]benzamide
5-O-[(S)-[(2-Aminobenzoyl)oxy](Hydroxy)phosphoryl]adenosine
N-[[5-(1H-benzimidazol-2-yl)-2-chloroanilino]-sulfanylidenemethyl]-2,6-dimethoxybenzamide
C23H19ClN4O3S (466.0866334000001)
1,3-Diphenyl-4-pyrazolecarboxylic acid [2-[(3,5-dichloro-2-pyridinyl)amino]-2-oxoethyl] ester
N-[(6-chloro-1H-benzimidazol-2-yl)methyl]-2-(4-morpholinyl)-9-(3-thiophenyl)-6-purinamine
C21H19ClN8OS (466.10909940000005)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetic acid
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetic acid
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetic acid
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetic acid
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid
3,4,5-Trihydroxy-6-[4-[3-oxo-3-(2,3,4,6-tetrahydroxyphenyl)propyl]phenoxy]oxane-2-carboxylic acid
4-[4-[(5Z)-5-[(Z)-2-Methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid
[2-(5,7-Dihydroxy-4-oxo-2-phenylchromen-8-yl)-4,5-dihydroxyoxan-3-yl] hydrogen sulate
3,4,5-Trihydroxy-2-[hydroxy(3,4,5-trihydroxyoxan-2-yl)methyl]-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohexa-2,5-dien-1-one
(3S,4aS,5S)-6-chloro-3-(dimethylamino)-1,5,9,10,11a-pentahydroxy-5-methyl-2,11-dioxo-3,3a,4,4a-tetrahydrocyclopenta[b]anthracene-1-carboxamide
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 4-aminobenzoate
(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-[(3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,3-dihydrochromen-4-one
4-[(2S,3R,4S,5S,6R)-6-[(3,4-dihydroxybenzoyl)oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxybenzoic acid
(2S,3S)-3,5,7-trihydroxy-2-[4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one
6-chloro-5-methyl-N-[6-(2-methylpyridin-3-yl)oxypyridin-3-yl]-2,3-dihydroindole-1-carboxamide;dihydrochloride
Quercetin 7-O-beta-D-glucoside
A quercetin O-glucoside in which a glucosyl residue is attached at position 7 of quercetin via a beta-glycosidic linkage.
(2r,3s)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
3-hydroxy-2-(2-hydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyl)-5-(hydroxymethyl)benzoic acid
2,3-dihydroxypropoxy(3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)-2-hydroxypropyl)phosphinic acid
C13H28AsO11P (466.0585128000001)
2-{[2-({[2-(6-chloro-4-hydroxy-1-methylindol-3-yl)-4-methyl-5h-1,3-oxazol-4-yl](hydroxy)methylidene}amino)-1-hydroxypropylidene]amino}-3-hydroxypropanoic acid
6,8-dihydroxy-3-methyl-1-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]tetraphene-7,12-dione
4,6,12-trihydroxy-8,16-bis(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaen-9-one
(2r)-5,7-dihydroxy-2-[(2s,3s)-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1-benzofuran-4-yl]-2,3-dihydro-1-benzopyran-4-one
methyl (5e)-7-[(1e,2r)-2-(acetyloxy)-4-bromo-2-[(2z)-oct-2-en-1-yl]-5-oxocyclopent-3-en-1-ylidene]hept-5-enoate
(2s,3s)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
(2r,3r)-3-ethyl-7,9-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one
2-(4-hydroxy-3-methoxyphenyl)-3,7,12-trimethoxy-2,3-dihydro-1,4,5-trioxatetraphen-10-one
(2s,3r)-2-(4-hydroxy-3-methoxyphenyl)-3,7,12-trimethoxy-2,3-dihydro-1,4,5-trioxatetraphen-10-one
(2s)-2-{[(2r)-2-({[(4r)-2-(6-chloro-4-hydroxy-1-methylindol-3-yl)-4-methyl-5h-1,3-oxazol-4-yl](hydroxy)methylidene}amino)-1-hydroxypropylidene]amino}-3-hydroxypropanoic acid
(2s)-5,7-dihydroxy-2-[(2r,3r)-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1-benzofuran-4-yl]-2,3-dihydro-1-benzopyran-4-one
2-hydroxy-5-({3,4,5-trihydroxy-6-[(4-hydroxy-3-methoxybenzoyloxy)methyl]oxan-2-yl}oxy)benzoic acid
(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-(3,4,5-trihydroxyphenoxy)oxan-2-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,3-dihydro-1-benzopyran-4-one
(2R, 3R)- taxifolin-3-'O-B-D- glucopyranoside
{"Ingredient_id": "HBIN006458","Ingredient_name": "(2R, 3R)- taxifolin-3-'O-B-D- glucopyranoside","Alias": "NA","Ingredient_formula": "C21H22O12","Ingredient_Smile": "C1=CC(=C(C=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42688","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2S,3S)-(-)-taxifolin-3-O-β-D-glucoside
{"Ingredient_id": "HBIN006734","Ingredient_name": "(2S,3S)-(-)-taxifolin-3-O-\u03b2-D-glucoside","Alias": "NA","Ingredient_formula": "C21H22O12","Ingredient_Smile": "C1=CC(=C(C=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41668","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-o-β-d-(6-o-vanilloyl glucopyranosyl)gentisicacid
{"Ingredient_id": "HBIN011835","Ingredient_name": "5-o-\u03b2-d-(6-o-vanilloyl glucopyranosyl)gentisicacid","Alias": "NA","Ingredient_formula": "C21H22O12","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22326","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-(3,4-dihydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
1,8-dihydroxy-5,6-dimethoxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
3-ethyl-7,9-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one
2-[(3,4-dihydroxyphenyl)methyl]-2,6-dihydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-benzofuran-3-one
3,5,7-trihydroxy-2-(4-hydroxyphenyl)-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
6,8-dihydroxy-3-methyl-1-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}tetraphene-7,12-dione
2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-9,12-dimethoxy-2,3-dihydro-1,4,5-trioxatetraphen-10-one
(2s,3r)-3-{[(2s,3r,4r,5r)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
(2s,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
methyl 7-[2-(acetyloxy)-4-bromo-2-(oct-2-en-1-yl)-5-oxocyclopent-3-en-1-ylidene]hept-5-enoate
1,8-dihydroxy-4,5-dimethoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
3-(acetyloxy)-5-(4-hydroxyphenyl)-6,11,12-trimethoxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl acetate
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,8a-dihydrochromen-4-one
(2r,3s)-3,5,7-trihydroxy-2-(4-hydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-2,3-dihydro-1-benzopyran-4-one
(2r,3r)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
3-hydroxy-2-(2-hydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyl)-5-(hydroxymethyl)benzoic acid
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
(2r,3r)-3-(3,4-dihydroxyphenyl)-2,8-dihydroxy-6-{[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}-2,3-dihydro-1-benzopyran-4-one
2,5-dihydroxy-1,6-dimethoxy-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
(2s,3s)-5,7-dihydroxy-3-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(2s)-2-{[(2r)-2-({[(4s)-2-(6-chloro-4-hydroxy-1-methylindol-3-yl)-4-methyl-5h-1,3-oxazol-4-yl](hydroxy)methylidene}amino)-1-hydroxypropylidene]amino}-3-hydroxypropanoic acid
3,5-dihydroxy-6-(hydroxymethyl)-4-(3,4,5-trihydroxyphenoxy)oxan-2-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(2s,3r)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-{[(2s,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
(2e)-1-(2,4-dihydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(3,4,5-trihydroxyphenyl)prop-2-en-1-one
2-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[(4-hydroxy-3-methoxybenzoyloxy)methyl]oxan-2-yl]oxy}benzoic acid
(8s)-4,6,12-trihydroxy-8,16-bis(4-hydroxyphenyl)-15-oxatetracyclo[8.6.1.0²,⁷.0¹⁴,¹⁷]heptadeca-1(16),2,4,6,10(17),11,13-heptaen-9-one
(1s)-17-(6-hydroxy-1-benzofuran-2-yl)-11-methyl-2,20-dioxapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-3,5,7,9(21),10,12,14,16,18-nonaene-1,5,15-triol
(2r,3s)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
3,5,7-trihydroxy-2-(4-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-2,3-dihydro-1-benzopyran-4-one
1,8-dihydroxy-4,5-dimethoxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
3,8-dihydroxy-4,5-dimethoxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
[(2s,4r,5s,6s,7r)-5,6,12,13,14-pentahydroxy-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-4-yl]methyl 3,4,5-trihydroxybenzoate
3-(3,4-dihydroxyphenyl)-2,8-dihydroxy-6-[(3,4,5,6-tetrahydroxyoxan-2-yl)methoxy]-2,3-dihydro-1-benzopyran-4-one
1-(2,4-dihydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(3,4,5-trihydroxyphenyl)prop-2-en-1-one
(2r)-3-{4,5-dihydroxy-2-[(4-hydroxyphenyl)methyl]phenyl}-2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoic acid
1,8-dihydroxy-2,6-dimethoxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
(2s,3s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,3-dihydro-1-benzopyran-4-one
17-(6-hydroxy-1-benzofuran-2-yl)-11-methyl-2,20-dioxapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-3,5,7,9(21),10,12,14,16,18-nonaene-1,5,15-triol
(2s,3r)-5,7-dihydroxy-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(2s,4r,5r,6s,7s)-5,12,13,14-tetrahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(14),10,12-trien-6-yl 3,4,5-trihydroxybenzoate
(2s)-2-(3,5-dihydroxyphenyl)-5,6-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
(2s,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
3,8-dihydroxy-4,5-dimethoxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
1,8-dihydroxy-2,6-dimethoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
5,12,13,14-tetrahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-6-yl 3,4,5-trihydroxybenzoate
3-{4,5-dihydroxy-2-[(4-hydroxyphenyl)methyl]phenyl}-2-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoic acid
(2r,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,3-dihydro-1-benzopyran-4-one
3-{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-1-benzopyran-4-one
(4as,8as)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,8a-dihydrochromen-4-one
methyl (5e)-7-[(1e)-2-(acetyloxy)-4-bromo-2-(oct-2-en-1-yl)-5-oxocyclopent-3-en-1-ylidene]hept-5-enoate
2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-12-methoxy-2,3-dihydro-1,4,5-trioxatetraphen-10-one
1,8-dihydroxy-5,6-dimethoxy-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
(2s,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
(2s,3s)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
(14s,15s)-14-(4-hydroxyphenyl)-23-oxahexacyclo[11.8.1.1²,²⁰.0³,⁸.0⁹,²².0¹⁶,²¹]tricosa-1,3(8),4,6,9(22),10,12,16,18,20-decaene-6,10,12,15,18-pentol
(2r,3r)-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-12-methoxy-2,3-dihydro-1,4,5-trioxatetraphen-10-one
(2s,3r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
{5,6,12,13,14-pentahydroxy-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-4-yl}methyl 3,4,5-trihydroxybenzoate
3-(acetyloxy)-5-[4-(acetyloxy)phenyl]-6,11,12-trihydroxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl acetate
(2r)-2-[(3,4-dihydroxyphenyl)methyl]-2,6-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-benzofuran-3-one
(2s,3r)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
(2s,3r)-5,7-dihydroxy-3-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(2r,3s)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-{[(2s,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
(2r)-2,3-dihydroxypropoxy((2s)-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-hydroxypropyl)phosphinic acid
C13H28AsO11P (466.0585128000001)